Director/PDMR Shareholding

RNS Number : 5321X
Primary Health Properties PLC
17 August 2009
 



Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons


All relevant boxes should be completed in block capital letters.


1.

Name of the issuer


PRIMARY HEALTH PROPERTIES PLC

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R, 

(ii) a disclosure made in accordance 

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).


Both (i) and (ii)





3.

Name of person discharging managerial

responsibilities/director


Harry Hyman

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person


Connected to Director Harry Hyman







5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1


Purchase by Nexus Group Holdings Limited 

Non beneficial interest of Director.


 

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares


Ordinary Shares of 50 pence each





7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them


Total holding following transaction:


Smith & Williamson Nominees Limited

2,280,135


   

State the nature of the transaction


Acquisition of 400 new Ordinary Shares by Nexus Group Holdings Limited 

All new Ordinary shares held by Nexus Group Holdings Limited (being a total of 2,280,135 ordinary shares including this purchaseare subject to the debenture and fixed charge by its bank over all of its assets.







9.

Number of shares, debentures or financial

instruments relating to shares acquired


N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A





11.

Number of shares, debentures or financial

instruments relating to shares disposed


12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)


N/A


N/A

13.

Price per share or value of transaction


299.9p


14.

Date and place of transaction


17 August 2009, LONDON





15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)


  46,858          BENEFICIAL

2,357,885    NON-BENEFICIAL 

TOTAL  2,404,643  6.82%

16.

Date issuer informed of transaction



17 August 2009








If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes


17.

Date of grant



18.

Period during which or date on which exercisable







19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)







21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise



22.

Total number of shares or debentures over which options held following notification






23.

Any additional information


24.

Name of contact and telephone number for queries


RACHEL BUTLIN, COMPANY SECRETARY, J O HAMBRO CAPITAL MANAGEMENT LIMITED
0207 747 5680







Name of authorised official of issuer responsible for making notification


FOR AND ON BEHALF OF J O HAMBRO CAPITAL MANAGEMENT LIMITED AS COMPANY SECRETARY OF PRIMARY HEALTH PROPERTIES PLC


………………………………………..


RACHEL BUTLIN, COMPANY SECRETARY


Date of notification  17  August 2009









Notes:    This form is intended for use by an issuer to make a RIS notification required by DR 3.3.


(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDISUBGGCR
UK 100

Latest directors dealings